Home / Stocks / MCK

McKesson (MCK, Drug & medical wholesalers) Stock Valuation & Fair Value

Significantly overvalued

McKesson (MCK, Drug & medical wholesalers) trades at a current P/E of 25.0, about 64% above its historical normal valuation, with a forward growth estimate of 14.1% and a PEG of 1.78. Analysts' one-year estimates have been hit 82% of the time. Priced at its historical normal P/E of 15.3 on the same blended earnings, the 2026-11-10 close of $1,082.59 corresponds to about $660 a share. This is a valuation reference, not a price target.

How to read these numbers: the PEG ratio and current P/E versus normal P/E.

Current P/E
25.0
Normal P/E
15.3
PEG
1.78
Fwd growth
14.1%
Div yield
0.3%
RSI (14)
73.0
Overbought
Technical context
  • Price $1,082.59 at the Nov 10 close, 6.7% above the 20-day average ($1,014.37) and 14.6% above the 50-day ($944.96).
  • RSI (14) at 73.0.
  • 52-week range $723.60 to $1,082.59: the price is at the high and 49.6% above the low.

The Street vs SeerForecast

Wall Street's mean price target for MCK is $1,129.07 across 14 analysts, 4.3% above the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: significantly overvalued. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating moved from trading above its usual valuation (2026-06-03) to significantly overvalued (2026-11-09).

Current P/E and rating by weekCurrent P/E moved from 19.0 to 24.5 between 2026-06-03 and 2026-11-06, against a normal P/E of 15.3, with 3 rating changes over 22 recorded weeks.2026-06-03: P/E 19.0, Trading above its usual valuation, recalculated for the week of 2026-06-032026-06-10: P/E 19.4, Trading above its usual valuation, recalculated for the week of 2026-06-102026-06-12: P/E 19.4, Trading above its usual valuation, recalculated for the week of 2026-06-142026-06-16: P/E 19.4, Trading above its usual valuation, recalculated for the week of 2026-06-162026-06-18: P/E 19.4, Trading above its usual valuation, recalculated for the week of 2026-06-212026-07-02: P/E 19.0, Trading above its usual valuation, recalculated for the week of 2026-07-022026-07-06: P/E 19.5, Trading above its usual valuation, recalculated for the week of 2026-07-062026-07-09: P/E 19.5, Trading above its usual valuation, recalculated for the week of 2026-07-092026-07-10: P/E 19.9, Trading above its usual valuation, recalculated for the week of 2026-07-122026-07-13: P/E 19.9, Trading above its usual valuation, recalculated for the week of 2026-07-132026-07-14: P/E 19.9, Trading above its usual valuation, recalculated for the week of 2026-07-142026-07-20: P/E 20.7, Trading above its usual valuation, recalculated for the week of 2026-07-202026-07-22: P/E 20.7, Trading above its usual valuation, recalculated for the week of 2026-07-222026-07-24: P/E 20.6, Trading above its usual valuation, recalculated for the week of 2026-07-252026-07-27: P/E 20.6, Trading above its usual valuation, recalculated for the week of 2026-07-272026-07-31: P/E 21.2, Trading above its usual valuation, recalculated for the week of 2026-07-312026-07-31: P/E 21.0, Trading above its usual valuation, recorded live 2026-08-032026-08-07: P/E 21.2, Trading above its usual valuation, recalculated for the week of 2026-08-072026-08-07: P/E 21.2, Trading above its usual valuation, recorded live 2026-08-102026-08-14: P/E 20.8, Trading above its usual valuation, recalculated for the week of 2026-08-142026-08-14: P/E 21.1, Trading above its usual valuation, recorded live 2026-08-172026-08-21: P/E 20.3, Trading above its usual valuation, recalculated for the week of 2026-08-212026-08-21: P/E 20.8, Trading above its usual valuation, recorded live 2026-08-242026-08-27: P/E 20.8, Trading above its usual valuation, recalculated for the week of 2026-08-272026-08-28: P/E 21.5, Significantly overvalued, recalculated for the week of 2026-08-282026-08-28: P/E 21.6, Significantly overvalued, recalculated for the week of 2026-08-302026-08-28: P/E 21.6, Significantly overvalued, recorded live 2026-08-312026-09-04: P/E 21.9, Significantly overvalued, recalculated for the week of 2026-09-052026-09-04: P/E 21.9, Significantly overvalued, recorded live 2026-09-072026-09-11: P/E 21.2, Trading above its usual valuation, recalculated for the week of 2026-09-122026-09-11: P/E 21.2, Trading above its usual valuation, recorded live 2026-09-142026-09-18: P/E 21.0, Trading above its usual valuation, recalculated for the week of 2026-09-192026-09-18: P/E 21.0, Trading above its usual valuation, recorded live 2026-09-212026-09-25: P/E 20.7, Trading above its usual valuation, recalculated for the week of 2026-09-262026-09-25: P/E 20.7, Trading above its usual valuation, recorded live 2026-09-282026-10-02: P/E 21.5, Significantly overvalued, recalculated for the week of 2026-10-032026-10-02: P/E 21.5, Significantly overvalued, recorded live 2026-10-052026-10-09: P/E 22.3, Significantly overvalued, recalculated for the week of 2026-10-102026-10-09: P/E 22.3, Significantly overvalued, recorded live 2026-10-122026-10-16: P/E 23.9, Significantly overvalued, recalculated for the week of 2026-10-172026-10-16: P/E 23.9, Significantly overvalued, recorded live 2026-10-192026-10-23: P/E 23.7, Significantly overvalued, recalculated for the week of 2026-10-242026-10-23: P/E 23.7, Significantly overvalued, recorded live 2026-10-262026-10-30: P/E 23.5, Significantly overvalued, recalculated for the week of 2026-10-312026-10-30: P/E 23.5, Significantly overvalued, recorded live 2026-11-022026-11-06: P/E 24.5, Significantly overvalued, recalculated for the week of 2026-11-072026-11-06: P/E 24.5, Significantly overvalued, recorded live 2026-11-0917.520.022.5Jun 3Jul 12Aug 20Sep 28Nov 6Normal P/E 15.3
Trading above its usual valuationSignificantly overvaluedLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated are worked out from the metrics tickerseer archived that week.

Selected weeks: the first, the latest, every week the rating moved, and the cheapest and dearest.

WeekCurrent P/EPremium to normal P/ERating
2026-06-03P/E 19.0+24%Trading above its usual valuation (recalculated)
2026-08-28P/E 21.5+41%Significantly overvalued (recalculated)
2026-09-12P/E 21.2+39%Trading above its usual valuation (recalculated)
2026-10-03P/E 21.5+41%Significantly overvalued (recalculated)
2026-11-07P/E 24.5+61%Significantly overvalued (recalculated)
2026-11-09P/E 24.5+61%Significantly overvalued ← now
Show all 47 readings
WeekCurrent P/EPremium to normal P/ERating
2026-06-03P/E 19.0+24%Trading above its usual valuation (recalculated)
2026-06-10P/E 19.4+27%Trading above its usual valuation (recalculated)
2026-06-14P/E 19.4+27%Trading above its usual valuation (recalculated)
2026-06-16P/E 19.4+27%Trading above its usual valuation (recalculated)
2026-06-21P/E 19.4+27%Trading above its usual valuation (recalculated)
2026-07-02P/E 19.0+25%Trading above its usual valuation (recalculated)
2026-07-06P/E 19.5+28%Trading above its usual valuation (recalculated)
2026-07-09P/E 19.5+28%Trading above its usual valuation (recalculated)
2026-07-12P/E 19.9+30%Trading above its usual valuation (recalculated)
2026-07-13P/E 19.9+30%Trading above its usual valuation (recalculated)
2026-07-14P/E 19.9+30%Trading above its usual valuation (recalculated)
2026-07-20P/E 20.7+36%Trading above its usual valuation (recalculated)
2026-07-22P/E 20.7+36%Trading above its usual valuation (recalculated)
2026-07-25P/E 20.6+35%Trading above its usual valuation (recalculated)
2026-07-27P/E 20.6+35%Trading above its usual valuation (recalculated)
2026-07-31P/E 21.2+39%Trading above its usual valuation (recalculated)
2026-08-03P/E 21.0+37%Trading above its usual valuation
2026-08-07P/E 21.2+39%Trading above its usual valuation (recalculated)
2026-08-10P/E 21.2+39%Trading above its usual valuation
2026-08-14P/E 20.8+36%Trading above its usual valuation (recalculated)
2026-08-17P/E 21.1+38%Trading above its usual valuation
2026-08-21P/E 20.3+33%Trading above its usual valuation (recalculated)
2026-08-24P/E 20.8+36%Trading above its usual valuation
2026-08-27P/E 20.8+36%Trading above its usual valuation (recalculated)
2026-08-28P/E 21.5+41%Significantly overvalued (recalculated)
2026-08-30P/E 21.6+42%Significantly overvalued (recalculated)
2026-08-31P/E 21.6+42%Significantly overvalued
2026-09-05P/E 21.9+43%Significantly overvalued (recalculated)
2026-09-07P/E 21.9+43%Significantly overvalued
2026-09-12P/E 21.2+39%Trading above its usual valuation (recalculated)
2026-09-14P/E 21.2+39%Trading above its usual valuation
2026-09-19P/E 21.0+37%Trading above its usual valuation (recalculated)
2026-09-21P/E 21.0+37%Trading above its usual valuation
2026-09-26P/E 20.7+36%Trading above its usual valuation (recalculated)
2026-09-28P/E 20.7+36%Trading above its usual valuation
2026-10-03P/E 21.5+41%Significantly overvalued (recalculated)
2026-10-05P/E 21.5+41%Significantly overvalued
2026-10-10P/E 22.3+46%Significantly overvalued (recalculated)
2026-10-12P/E 22.3+46%Significantly overvalued
2026-10-17P/E 23.9+56%Significantly overvalued (recalculated)
2026-10-19P/E 23.9+56%Significantly overvalued
2026-10-24P/E 23.7+55%Significantly overvalued (recalculated)
2026-10-26P/E 23.7+55%Significantly overvalued
2026-10-31P/E 23.5+54%Significantly overvalued (recalculated)
2026-11-02P/E 23.5+54%Significantly overvalued
2026-11-07P/E 24.5+61%Significantly overvalued (recalculated)
2026-11-09P/E 24.5+61%Significantly overvalued ← now

Frequently asked questions

Is McKesson stock overvalued?

At a current P/E of 25.0 versus its historical normal P/E of 15.3, McKesson trades about 64% above its typical valuation, with a PEG of 1.78 on 14.1% forward growth. tickerseer currently rates it significantly overvalued.

What is McKesson's fair value and PEG?

McKesson trades at a current P/E of 25.0 against a historical normal P/E of 15.3, a PEG of 1.78, and a forward growth estimate of 14.1%. Priced at its historical normal P/E of 15.3 on the same blended earnings, the 2026-11-10 close of $1,082.59 corresponds to about $660 a share. This is a valuation reference, not a price target.

Has tickerseer's rating of McKesson changed?

tickerseer's rating moved from trading above its usual valuation (2026-06-03) to significantly overvalued (2026-11-09).

What is the analyst price target for McKesson?

The mean Wall Street price target for McKesson is $1,129.07 across 14 analysts, 4.3% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Drug & medical wholesalers. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and an AI research note where we have one. Options setups and metric history are part of the paid plans.

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.